Therapeutic targeting of autophagy in neurodegenerative and infectious diseases.
Change log
Authors
Abstract
Autophagy is a conserved process that uses double-membrane vesicles to deliver cytoplasmic contents to lysosomes for degradation. Although autophagy may impact many facets of human biology and disease, in this review we focus on the ability of autophagy to protect against certain neurodegenerative and infectious diseases. Autophagy enhances the clearance of toxic, cytoplasmic, aggregate-prone proteins and infectious agents. The beneficial roles of autophagy can now be extended to supporting cell survival and regulating inflammation. Autophagic control of inflammation is one area where autophagy may have similar benefits for both infectious and neurodegenerative diseases beyond direct removal of the pathogenic agents. Preclinical data supporting the potential therapeutic utility of autophagy modulation in such conditions is accumulating.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1540-9538
Volume Title
Publisher
Publisher DOI
Sponsorship
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)
Wellcome Trust (100140/Z/12/Z)
Wellcome Trust (095317/Z/11/A)